Company: ANIX
Filing Date: 2025-03-11
Form Type: 10-Q
Source: 0001493152-25-009854
Chunk: 25

Company: Anixa Biosciences Inc
Filing Date: 2025-03-11
Form: 10-Q
Item: Part I, Item 8
Chunk 25
---
 litigation
or legal proceeding against us that would have a material adverse effect upon our results of operations or financial condition.

Item 1A. Risk
Factors.

There have been no material changes
in our risk factors from those disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2024.

Item 2. Unregistered
Sales of Equity Securities and Use of Proceeds. None.

Item 3. Defaults
Upon Senior Securities. None.

Item 4.
Mine Safety Disclosures. Not Applicable.

Item 5. Other
Information. None.

Item 6. Exhibits.

    31.1
    Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated March 11, 2025.

    31.2
    Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated March 11, 2025.

    32.1
    Statement of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated March 11, 2025.

    32.2
    Statement of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated March 11, 2025.

    101.INS
    Inline XBRL Instance Document

    101.SCH
    Inline XBRL Taxonomy Extension Schema

    101.CAL
    Inline XBRL Taxonomy Extension Calculation Linkbase

    101.DEF
    Inline XBRL Taxonomy Extension Definition Linkbase

    101.LAB
    Inline XBRL Taxonomy Extension Label Linkbase

    101.PRE
    Inline XBRL Taxonomy Extension Presentation Linkbase

    104
    Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

 20 

SIGNATURES

Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    ANIXA BIOSCIENCES, INC.

    By:
    /s/ Dr. Amit Kumar

    Dr. Amit Kumar

    Chairman and Chief Executive Officer 
  
    March 11, 2025
     
    (Principal Executive Officer)

    By: